SONI MANMEET SINGH (Chief Financial Officer) sold 53.8% of their position (75K shares) of REATA PHARMACEUTICALS INC on the open market
Open‑market sale worth $12.35M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A common stock
Shares
+75K
Price / share
—
Trade value
—
% of position
Class A common stock
Shares
−75K
Price / share
$164.62
Trade value
$12.35M
% of position
Net shares
+0.00
Net value
-$12.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A common stock Direct | 7/28/2023 | C · Conversion | +75K | — | — | 116.5% | 64.38K | 139.38K |
| Class A common stock Direct | 7/28/2023 | S · Sale | −75K | $164.62 | $12.35M | 53.8% | 139.38K | 64.38K |
| Total | +0.00 | -$12.35M | ||||||
Employee Stock Option (right to buy)
Class B common stock
75K shares
Shares
−75K
Strike price
72.70
Held after
175K
Exercisable
—
Class B common stock
Class A common stock
75K shares
Shares
+75K
Strike price
Held after
75K
Exercisable
—
Class B common stock
Class A common stock
75K shares
Shares
−75K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Class B common stock75K shares | 7/28/2023 | M · Option Exercise | −75K | 72.70 | — | 175K |
| Class B common stock Direct | Class A common stock75K shares | 7/28/2023 | M · Option Exercise | +75K | — | 75K | |
| Class B common stock Direct | Class A common stock75K shares | 7/28/2023 | C · Conversion | −75K | — | 0.00 |